PRAGUE, Czech Republic & AMSTERDAM, The Netherlands I March 13, 2025 I SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will be exercising its option, ...
SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will be exercising its option, under its license and option agreement with Synaffix B.V. (“Synaffix”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback